Published in Cancer Weekly, November 9th, 2004
"Cisplatin is one of the most widely used and effective chemotherapeutic agents for the treatment of several human malignancies," oncologists in the United States explained. "Although the effectiveness of cisplatin is high, its toxicities justify the demand for improved formulations of this drug."
"A liposomal formulation of cisplatin, Lipoplatin, was developed in order to reduce the systemic toxicity of cisplatin," according to P. Devarajan and colleagues at the University of Cincinnati.
"Mice and rats injected with cisplatin developed renal insufficiency with...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.